Free Trial

Nevro (NVRO) Stock Forecast & Price Target

$9.83
+0.33 (+3.47%)
(As of 07/23/2024 ET)

Nevro - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 13 Wall Street analysts who have issued ratings for Nevro in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 13 analysts, 2 have given a sell rating, 10 have given a hold rating, and 1 has given a buy rating for NVRO.

Consensus Price Target

$17.71
80.14% Upside
High Forecast$40.00
Average Forecast$17.71
Low Forecast$8.20

According to the 13 analysts' twelve-month price targets for Nevro, the average price target is $17.71. The highest price target for NVRO is $40.00, while the lowest price target for NVRO is $8.20. The average price target represents a forecasted upside of 80.14% from the current price of $9.83.

TypeCurrent Forecast
7/25/23 to 7/24/24
1 Month Ago
6/25/23 to 6/24/24
3 Months Ago
4/26/23 to 4/25/24
1 Year Ago
7/25/22 to 7/25/23
Consensus Rating
Reduce
Reduce
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
3 Buy rating(s)
Hold
10 Hold rating(s)
10 Hold rating(s)
11 Hold rating(s)
8 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$17.71$19.46$21.23$36.50
Forecasted Upside80.14% Upside26.91% Upside25.15% Upside13.92% Upside
Get Nevro Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NVRO and its competitors with MarketBeat's FREE daily newsletter.

NVRO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NVRO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Nevro Stock vs. The Competition

TypeNevroMedical CompaniesS&P 500
Consensus Rating Score
1.92
2.72
2.51
Consensus RatingReduceModerate BuyModerate Buy
Predicted Upside80.14% Upside2,973.09% Upside9.26% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/16/2024Truist Financial
1 of 5 stars
 Lower TargetHold ➝ Hold$11.00 ➝ $10.00+1.94%
7/15/2024Morgan Stanley
3 of 5 stars
 Lower TargetEqual Weight ➝ Equal Weight$14.00 ➝ $9.00-4.26%
7/10/2024Citigroup
3 of 5 stars
 Lower TargetSell ➝ Sell$9.00 ➝ $8.20+2.37%
5/8/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$17.00 ➝ $11.00+5.97%
5/8/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$14.00 ➝ $13.00+23.46%
5/8/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight ➝ Underweight$15.00 ➝ $12.00+4.08%
4/15/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSector Perform ➝ Sector Perform$18.00 ➝ $16.00+28.62%
4/11/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$20.00 ➝ $16.00+20.30%
2/22/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$23.00 ➝ $19.00+15.15%
2/22/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
11/2/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$23.00 ➝ $18.00+20.00%
8/2/2023JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$75.00 ➝ $40.00+62.14%
11/2/2022William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Vazquez
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
10/12/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageUnderperform$31.00-16.98%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 09:16 AM ET.

NVRO Forecast - Frequently Asked Questions

What is Nevro's forecast for 2024?

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Nevro is $17.71, with a high forecast of $40.00 and a low forecast of $8.20.

Should I buy or sell Nevro stock right now?

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nevro in the last twelve months. There are currently 2 sell ratings, 10 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "reduce" NVRO shares.

Does Nevro's stock price have much upside?

According to analysts, Nevro's stock has a predicted upside of 28.20% based on their 12-month stock forecasts.

Has Nevro been downgraded by Wall Street analysts recently?

Over the previous 90 days, Nevro's stock had 1 downgrade by analysts.

What analysts cover Nevro?

Nevro has been rated by research analysts at Canaccord Genuity Group, Citigroup, Morgan Stanley, Piper Sandler, Truist Financial, and Wells Fargo & Company in the past 90 days.

Do Wall Street analysts like Nevro more than its competitors?

Analysts like Nevro less than other "medical" companies. The consensus rating for Nevro is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how NVRO compares to other companies.


This page (NYSE:NVRO) was last updated on 7/24/2024 by MarketBeat.com Staff

From Our Partners